Yubo International Biotech Limited
YBGJ · OTC
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4,152 | $11,278 | $49,255 | $53,103 |
| - Cash | $7 | $18 | $28 | $1,383 |
| + Debt | $479 | $790 | $2,694 | $315 |
| Enterprise Value | $4,624 | $12,051 | $51,921 | $52,036 |
| Revenue | $3 | $104 | $1,244 | $1,354 |
| % Growth | -96.7% | -91.6% | -8.1% | – |
| Gross Profit | -$209 | $53 | $821 | $1,240 |
| % Margin | -6,031% | 50.5% | 65.9% | 91.6% |
| EBITDA | -$1,799 | -$1,178 | -$1,521 | -$699 |
| % Margin | -51,831.2% | -1,129.3% | -122.3% | -51.6% |
| Net Income | -$1,775 | -$1,205 | -$1,542 | -$712 |
| % Margin | -51,161.5% | -1,155.3% | -123.9% | -52.6% |
| EPS Diluted | -0.015 | -0.01 | -0.013 | -0.006 |
| % Growth | -46.5% | 22.9% | -118.3% | – |
| Operating Cash Flow | -$1,338 | $68 | -$1,021 | $101 |
| Capital Expenditures | $0 | -$40 | -$565 | -$97 |
| Free Cash Flow | -$1,338 | $28 | -$1,586 | $4 |